Atreca, Inc. Non-current Revenue (Deferred)

Non-current Revenue (Deferred) of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-current Revenue (Deferred) growth rates and interactive chart.


Highlights and Quick Summary

  • Non-current Revenue (Deferred) for the quarter ending September 30, 2022 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Non-current Revenue (Deferred) decreased by -100.0%
  • Annual Non-current Revenue (Deferred) for 2021 was $28.2 Million (a 124.31% increase from previous year)
  • Annual Non-current Revenue (Deferred) for 2020 was $12.6 Million (a 1549.41% increase from previous year)
  • Annual Non-current Revenue (Deferred) for 2019 was $763 Thousand (a 12616.67% increase from previous year)
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-current Revenue (Deferred) of Atreca, Inc.

Most recent Non-current Revenue (Deferred)of BCEL including historical data for past 10 years.

Interactive Chart of Non-current Revenue (Deferred) of Atreca, Inc.

Atreca, Inc. Non-current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0 $0.0 $0.0
2021 $28.23 $28.68 $27.93 $21.65 $28.23
2020 $12.59 $4.62 $2.89 $1.43 $12.59
2019 $0.76 $0.12 $0.02 $0.0 $0.76
2018 $0.01 $0.0 $0.0 $0.01

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology